Molecule Details

Drug(s) of This Target
1 Bupropion  Drug Info  Approved Nicotine use disorder
2 Diethylpropion  Drug Info  Approved Obesity
3 Duloxetine  Drug Info  Approved Depression
4 Imipramine  Drug Info  Approved Depression
5 Paracetamol  Drug Info  Approved Pain
6 Tapentadol  Drug Info  Approved Acute pain
7 Venlafaxine  Drug Info  Approved Depression
References
Reference 1 Clinically relevant drug interactions with new generation antidepressants and antipsychotics. Ther Umsch. 2009 Jun;66(6):485-92.
Reference 2 Pharmacotherapy for obesity. Drugs. 2005;65(10):1391-418.
Reference 3 Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov Today. 2007 Jan;12(1-2):34-42.
Reference 4 Invivo antioxidant status: a putative target of antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):220-8.
Reference 5 Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice. Psychopharmacology (Berl). 2009 Sep;206(1):97-107.
Reference 6 2008 FDA drug approvals. Nat Rev Drug Discov. 2009 Feb;8(2):93-6.